🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

437,23 USD

Máx. histórico

447,03

10 días

Split 2:1 del 22/11/1999

Caída desde máximo

-2,19%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-1,55%

Cierre anterior

444,12

Rango de hoy

435,01 – 441,66

Volumen hoy

1.656.089

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
27,17 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 3 días
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,27%
Fecha de pago Importe por participación
16/11/2022 1,9400 USD
17/08/2022 1,9400 USD
16/05/2022 1,9400 USD
14/02/2022 1,9400 USD
15/11/2021 1,7600 USD
16/08/2021 1,7600 USD
14/05/2021 1,7600 USD
11/02/2021 1,7600 USD
13/11/2020 1,6000 USD
14/08/2020 1,6000 USD
15/05/2020 1,6000 USD
13/02/2020 1,6000 USD
14/11/2019 1,4500 USD
14/08/2019 1,4500 USD
16/05/2019 1,4500 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/02/2010 57,54 58,03 56,64 57,68 +0,26% 2,42% 8.409.900
04/02/2010 58,90 59,06 57,33 57,53 -2,61% 2,94% 9.534.500
03/02/2010 58,90 59,42 58,86 59,07 -0,27% 0,95% 7.082.600
02/02/2010 58,60 59,30 58,41 59,23 +0,87% 1,52% 7.660.900
01/02/2010 58,52 58,84 58,37 58,72 +0,41% 0,80% 7.079.100
29/01/2010 58,35 58,93 58,16 58,48 +0,69% 1,32% 9.465.700
28/01/2010 57,87 58,78 57,56 58,08 +0,59% 2,11% 11.638.200
27/01/2010 56,35 57,88 56,35 57,74 +2,05% 2,72% 9.695.000
26/01/2010 56,20 56,87 55,70 56,58 +1,56% 2,08% 14.880.300
25/01/2010 56,72 56,79 55,55 55,71 -1,57% 2,19% 6.719.400
22/01/2010 56,67 57,30 56,53 56,60 -0,05% 1,36% 5.967.600
21/01/2010 57,43 57,56 56,31 56,63 -1,00% 2,18% 5.833.700
20/01/2010 57,62 57,62 56,41 57,20 -0,61% 2,10% 6.625.700
19/01/2010 56,41 57,75 56,24 57,55 +2,31% 2,68% 8.570.100
15/01/2010 56,03 56,51 55,65 56,25 +0,16% 1,53% 7.240.000
14/01/2010 56,35 56,53 55,91 56,16 -0,65% 1,10% 4.668.900
13/01/2010 56,35 56,75 55,96 56,53 +0,89% 1,40% 5.056.200
12/01/2010 57,14 57,42 54,82 56,03 -1,74% 4,55% 11.268.300
11/01/2010 56,93 57,36 56,62 57,02 +0,44% 1,30% 4.062.700
08/01/2010 56,07 56,83 55,64 56,77 +0,89% 2,12% 6.576.000
07/01/2010 56,41 56,53 54,65 56,27 -0,92% 3,33% 10.371.600
06/01/2010 56,94 57,39 56,50 56,79 -0,75% 1,56% 6.015.100
05/01/2010 57,33 57,69 56,27 57,22 -0,87% 2,48% 7.882.800
04/01/2010 56,63 57,87 56,56 57,72 +2,03% 2,31% 5.277.400
31/12/2009 57,47 57,50 56,57 56,57 -1,69% 1,62% 4.027.900
30/12/2009 57,51 57,80 57,30 57,54 +0,03% 0,87% 2.485.400
29/12/2009 57,77 57,92 57,17 57,52 -0,24% 1,30% 3.091.900
28/12/2009 57,48 57,73 57,23 57,66 +0,42% 0,87% 2.741.100
24/12/2009 57,16 57,45 56,90 57,42 +0,12% 0,96% 1.283.700
23/12/2009 57,49 57,67 57,05 57,35 +0,23% 1,08% 4.287.100